Healthpeak Properties Inc
SWB:HC5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healthpeak Properties Inc
SWB:HC5
|
US |
|
F
|
Farsoon Technologies Co Ltd
SSE:688433
|
CN |
|
Fastly Inc
NASDAQ:FSLY
|
US |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
K
|
Karyopharm Therapeutics Inc
F:25K
|
US |
|
Tuya Inc
F:7850
|
CN |
|
F
|
Fossil Group Inc
SWB:FSL
|
US |
Wall St Price Targets
HC5 Price Targets Summary
Healthpeak Properties Inc
According to Wall Street analysts, the average 1-year price target for HC5 is 16.85 EUR with a low forecast of 13.71 EUR and a high forecast of 25.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HC5's stock price target?
Price Target
16.85
EUR
According to Wall Street analysts, the average 1-year price target for HC5 is 16.85 EUR with a low forecast of 13.71 EUR and a high forecast of 25.83 EUR.
What is the Revenue forecast for Healthpeak Properties Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Healthpeak Properties Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been -6%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for Healthpeak Properties Inc?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been -17%. The projected CAGR for the next 8 years is 22%.
